Bridging the Gap: The Difference Between APIs and Finished Drugs
It's easy to get confused between Active Pharmaceutical Ingredients (APIs) and finished drugs, but understanding the difference is key to appreciating the pharmaceutical supply chain. An API is the active chemical component in a drug; it's the raw ingredient that has a therapeutic effect. A finished drug, on the other hand, is the final product you buy at a pharmacy, such as a tablet, capsule, or a bottle of liquid medicine. The finished drug is a formulation that contains the API, along with other inactive ingredients (known as excipients) that help to stabilize the API, facilitate its delivery, or improve its taste and appearance. India's pharmaceutical industry excels in both—it has a strong presence in API manufacturing and is a global leader in producing finished generic drugs. This backward integration, where companies can control both the raw material and the final product, gives India a significant competitive advantage. This strategic position is a defining feature of the INDIA API Market.